Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
deals
4
×
life sciences
national blog main
national top stories
san diego blog main
san diego top stories
4
×
startups
biotech
boston blog main
san francisco blog main
boston top stories
fda
ipo
m&a
medical devices
new york blog main
new york top stories
san francisco top stories
vc
wisconsin blog main
wisconsin top stories
3m ventures
abbvie
acetylon pharmaceuticals
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
ambys medicines
amunix
anirvan ghosh
apps
aptar pharma
asthma
asthmapolis
astrazeneca
atrial fibrillation
biogen
bluerock therapeutics
boehringer ingelheim
What
deal
4
×
acquire
medicines
startup
acquisition
acquisitions
adding
aiming
ambys
announced
atrial
big
bio
biotech
boosts
boston
business
ceo
collabs
connected
continues
control
covid
cryterion
daniel
deadly
debuted
device
devices
diseases
endorsement
fibrillation
formed
future
gilead
gilead’s
health
healthcare
heart
help
Language
unset
Current search:
deals
×
photo
×
deal
×
" san diego top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
ResMed Boosts Connected Health Play With $225M Propeller Health Deal
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
5 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion